FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897 Read more
FDA advisory committee votes on Zynquista (sotagliflozin) as treatment for adults with type 1 diabetes Read more
Phoenix Molecular Designs Announces Collaboration To Develop Diagnostic for Triple-Negative Breast Cancer Read more
Novartis receives European Commission approval for self-administration of Xolair across all indications Read more
AstraZeneca and Cancer Research UK launch Functional Genomics Centre to accelerate the discovery of new medicines Read more